As 2025 consumers increasingly seek natural ways to support attention, emotional balance, and metabolic wellness, Pilly Labs introduces a fruiting body mushroom gummy blend featuring Lion’s Mane, Reishi, and Cordyceps—positioned at the intersection of convenience, cognitive clarity, and ingredient transparency.
As 2025 consumers increasingly seek natural ways to support attention, emotional balance, and metabolic wellness, Pilly Labs introduces a fruiting body mushroom gummy blend featuring Lion’s Mane, Reishi, and Cordyceps—positioned at the intersection of convenience, cognitive clarity, and ingredient transparency.
NEW YORK, July 31, 2025 /PRNewswire/ -- Genpact (NYSE: G), an advanced technology services and solutions company, today announced that Thimaya Subaiya has been...
The THR‑β agonist market is witnessing rapid growth, fueled by the increasing global prevalence of metabolic disorders such as MASH and rare genetic conditions...
The THR‑β agonist market is witnessing rapid growth, fueled by the increasing global prevalence of metabolic disorders such as MASH and rare genetic conditions...
BORDEAUX, France, July 30, 2025 /PRNewswire/ -- Fresh, organic, vegan and enjoyable, the Mouton Cadet Fresh Collection takes a new approach to wine-drinking with...
The 2025 interim financial report, including the interim management report and the condensed consolidated interim financial statements at 30 June 2025, is available on the company’s website www.clariane.com. The condensed interim consolidated financial statements were approved by the Board of Directors at its meeting on 29 July 2025 and were subject to a limited review by the Statutory Auditors. The condensed interim consolidated financial statements have been prepared in accordance with IAS 34. For comparison purposes, the following financial information is presented excluding the application of IFRS 16
Delivered sequential net sales growth across all segments, despite negative consumer sentiment impacting global demandDelivered significant cost take out of 100 basis points or...
WOBURN, Mass., July 25, 2025 /PRNewswire/ -- Spear Bio, a biotechnology company pioneering homogeneous ultrasensitive immunoassay technology, today announced the commercial launch of its...
MADRID, 25 July 2025 – Neinor Homes (“Neinor”) (HOME SM), the leading residential platform in Spain, has announced its results for the first half of 2025, confirming the continued growth of its Asset Management business, solid operating margins, and a record commercialization activity. The period also marks an acceleration in the Company’s investment strategy with the launch of a voluntary tender offer for 100% of Aedas Homes’ capital.